The Medtronic Newsroom is designed to assist media in finding news and information about our company.

Medtronic, founded in a Minneapolis garage in 1949 by Earl Bakken and his brother-in-law, Palmer Hermundslie, is the world’s leading maker of medical devices.

Our Mission has not changed since Earl Bakken wrote it in 1960: To contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health and extend life.

More than 9 million lives are enhanced every year by a Medtronic product or therapy; that’s one every three seconds.

Medtronic is headquartered in Minneapolis, MN and operates in more than 140 countries. The company employs 49,000 people, including 5,800 scientists and engineers, pursuing research and innovation that has led to more than 28,000 patents.

Most Recent Press ReleasesRead More
11/26/14Medtronic Acquisition of Covidien Receives U.S. FTC Clearance
MINNEAPOLIS AND DUBLIN, Ireland - Nov. 26, 2014 - Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced the receipt of U.S. Federal Trade Commission (FTC) clearance of Medtronic's proposed acquisition of Covidien.  "This regulatory clearance represents an important milestone in bringing our companies together," said Omar Ishrak, Chairman and CEO of Medtronic.  "We continue to make good progress in planning for the integration of these two companies which will u... 
11/18/14Medtronic Reports Second Quarter Earnings
Revenue of $4.4 Billion Grew 5% on Constant Currency Basis; 4% as Reported Non-GAAP Diluted EPS of $0.96, Growth of 5%; GAAP Diluted EPS of $0.83, Decline of 7% Company Updates FY15 Revenue Growth Outlook; Reiterates FY15 EPS Guidance Company Reaffirms Commitment to Covidien Transaction MINNEAPOLIS - Nov. 18, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2015, which ended October 24, 2014. The company reported worldwide seco... 
11/17/14Medtronic and Covidien Shareholder Meetings Scheduled for January 6, 2015
MINNEAPOLIS AND DUBLIN - Nov. 17, 2014 - Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) announced that following a hearing today before the Irish High Court the companies have scheduled shareholder meetings for Tuesday, January 6, 2015, in connection with the pending acquisition of Covidien by Medtronic.  Medtronic's special shareholder meeting will be held on January 6, 2015 at 8:00 a.m. local time at the Hyatt Regency, 1300 Nicollet Mall, Minneapolis, MN, 55403. This meeting is bei... 
Medtronic in the News
10/03/14British runners among Medtronic Twin Cities Marathon’s Global Heroes – Athletics Weekly
05/03/14Med-Tech Industry is Booming in China – Minneapolis Star Tribune
02/18/14The 50 Smartest Companies for 2014 – MIT Technology Review
Receive E-mail Alerts E-mail Alert Icon
Sign up to receive e-mail alerts whenever Medtronic posts new information to the site. Just enter your e-mail address and click Submit.

Section Navigation


Medtronic to acquire Covidien. Learn More.

Media contact:
Fernando Vivanco


Contact Us

Medtronic, Inc.
main number(763) 514-4000
Public Relations
710 Medtronic Pkwy NE LC-110
Minneapolis, MN  55432

Media Contacts

Latest Tweets

Medtronic News

Latest Tweets

Omar Ishrak